Amphioxus tyrosine kinase SYK inhibits NF- κ B activation through MyD88-dependent mechanism
Journal of Molecular Cell Biology · 03.07.2026 · 18
DOI: 10.1093/jmcb/mjag009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Cell Biology, online erschienen am 16.03.2026. Verfasst von Jie Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Beijing University of Chinese Medicine, Beijing 102488, China. Hauptthemen laut MEDLINE: Lancelets, Myeloid Differentiation Factor 88, Syk Kinase, NF-kappa B. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, 111 Project.
Abstract (Originalsprache)
The spleen tyrosine kinase (SYK) plays pivotal roles in the adaptive immune response by recognizing phosphorylated immunoreceptor tyrosine-based activation motif (ITAM) and activating downstream effectors. However, the emergence of SYK predates the advent of adaptive immunity, and its original functions independent of the adaptive immune system remain largely unknown. In this study, we identified and characterized a SYK homolog (bjSYK) in the amphioxus Branchiostoma japonicum, a key model for understanding immune system evolution. Phylogenetic analysis positioned bjSYK basally among deuterostome SYK kinases. Expression analysis revealed its localization in immune-relevant tissues. Contrary to the canonical activating role in vertebrates, functional studies demonstrated that bjSYK acts as a potent suppressor of nuclear factor-kappa B (NF-κB) activation. Specifically, bjSYK directly interacts with bjMyD88 via its SH2 domains binding to a conserved hemi-ITAM motif, suppressing K63-linked polyubiquitination of bjMyD88 and consequently inhibiting bjMyD88-dependent NF-κB signaling. Furthermore, bjSYK also suppresses NF-κB activation through bjTRAF6, a key adaptor downstream of bjMyD88, by inhibiting its ubiquitination. These findings reveal an evolutionarily ancient inhibitory role of bjSYK in NF-κB signaling in basal chordate innate immunity, suggesting that SYK-mediated negative regulation of Toll-like receptor pathways originates in amphioxus and provides a foundation for the context-dependent functions of SYK in vertebrate immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Beijing University of Chinese Medicine, Beijing 102488, China.
- School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China.
- Sheng Yushou Center of Cell Biology and Immunology, Shanghai Jiao Tong University, Shanghai 200240, China.
- Guangdong Key Laboratory of Pharmaceutical Functional Genes, MOE Key Laboratory of Gene Function and Regulation, MOE Engineering Center of South China Sea Marine Biotechnology, Southern Laboratory of Ocean Science and E…
- Biomedical Research & Development Center, Sun Yat-sen University Institute of Advanced Studies Hong Kong, Hong Kong 999077, China.
ORCID-Profile: Anlong Xu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- 111 Project
Zitieren
APA
Xu, J., Hu, H., Lu, Q., Wei, Q., Zhang, Y., Huang, G., & Xu, A. (2026). Amphioxus tyrosine kinase SYK inhibits NF- κ B activation through MyD88-dependent mechanism. Journal of Molecular Cell Biology, 18. https://doi.org/10.1093/jmcb/mjag009
Vancouver
Xu J, Hu H, Lu Q, Wei Q, Zhang Y, Huang G, et al. Amphioxus tyrosine kinase SYK inhibits NF- κ B activation through MyD88-dependent mechanism. Journal of Molecular Cell Biology. 2026;18. doi:10.1093/jmcb/mjag009
BibTeX
@article{Xu2026,
author = {Xu, Jie and Hu, Haikun and Lu, Qingyi and Wei, Qiuzhu and Zhang, Yuhang and Huang, Guangrui and Xu, Anlong},
title = {Amphioxus tyrosine kinase SYK inhibits NF- κ B activation through MyD88-dependent mechanism},
journal = {Journal of Molecular Cell Biology},
year = {2026},
volume = {18},
doi = {10.1093/jmcb/mjag009}
}
EUVIMED